The Impact of Concomitant Medication Use on Patient Eligibility for Phase I Cancer Clinical Trials

Concomitant medication (CM) use may result in Phase I cancer clinical trial ineligibility due to concern for potential CM-investigational drug interactions or alteration of investigational drug absorption. Few studies have examined the impact of CM use on trial eligibility. Methods: We reviewed reco...

Descripción completa

Detalles Bibliográficos
Autores principales: Borad, Mitesh J., Curtis, Kelly K., Babiker, Hani M., Benjamin, Martin, Tibes, Raoul, Ramanathan, Ramesh K., Wright, Karen, Dueck, Amylou C., Jameson, Gayle, Von Hoff, Daniel D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2012
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434362/
https://www.ncbi.nlm.nih.gov/pubmed/22962561
http://dx.doi.org/10.7150/jca.4714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434362/
https://www.ncbi.nlm.nih.gov/pubmed/22962561
http://dx.doi.org/10.7150/jca.4714

Ejemplares similares